Enhancement of Lewis lung carcinoma by the concomitant infection of the host with herpes simplex virus type 1 and type 2

Pharmacology, Toxicology and Pharmaceutical Science

• Lewis Carcinoma 100%
• Human Alphaherpesvirus 1 66%
• Lung Metastasis 33%
• Herpes Simplex Virus 2 33%
• Virus Infectivity 33%
• Primary Tumor 33%
• Concurrent Infection 33%
• Herpes Simplex Virus 33%

Medicine and Dentistry

• Lewis Lung Carcinoma 100%
• Lung Metastasis 33%
• Virus Infectivity 33%
• Cancer Transplantation 33%
• Herpes Simplex Virus 2 33%

Immunology and Microbiology

• Acceleration 50%
• Herpes Simplex Virus 2 50%